↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
Medtronic$MDT · filed: grew revenue 8.4% in FY2026 to $36.4BNew shipTrillion Score 532Fall Risk LowNext year $35.1B–$40.3B sealedCheck ▾Close ▴
What Medtronic filed
Grew revenue 8.4% in FY2026 to $36.4 billion, operating margin 17.8% against a 7.5% median for electromedical & electrotherapeutic apparatus, equity 53.2% of assets, and dividend per share up 13 years running. Every figure links to the filing it came from on Medtronic’s card. New ship: no warning signs. Trillion Score 532, #42 of 116 in its field; Fall Risk Low (how it is measured).
What the house said in advance
Revenue for the fiscal year after 2026-04-24 between $35.1B and $40.3B, an 80% range sealed on 26 Sept 2026 · receipt #162bad · graded in public by the revenue in Medtronic’s next annual report.
Figures as filed with the SEC. Ranges, scores and boats are statistical descriptions of past filings, not ratings or recommendations. Reporting, not advice.
In plain words
Medtronic spins **$8B** MiniMed via exchange offer, retiring **4.3%** of shares while isolating diabetes underperformance ahead of 2025 product cycle.
$8.2B
Shareholders will exchange Medtronic common stock for MiniMed shares…
21-day
tender window and an expected close in late June
$2.1B
in trailing twelve-month revenue through March
6.5%
of Medtronic's consolidated topline
Medtronic announced an exchange offer to complete the separation of its MiniMed Group, the diabetes management division anchored by insulin pump technology that analysts value between $7.5B and $8.2B. Shareholders will exchange Medtronic common stock for MiniMed shares at a premium, with the parent retaining no post-transaction ownership. The offer launches in mid-May with a 21-day tender window and an expected close in late June, subject to IRS private letter ruling confirmation and regulatory clearance.
The MiniMed Group generated $2.1B in trailing twelve-month revenue through March, approximately 6.5% of Medtronic's consolidated topline. The unit's operating margin contracted 340 basis points year-over-year to 11.2% as competitive pressure from Tandem Diabetes and Insulet eroded market share in the automated insulin delivery segment. Medtronic's broader Diabetes Operating Unit, which includes continuous glucose monitoring assets retained post-spin, posted flat growth against a category expanding at 8-9% annually. The separation isolates MiniMed's underperformance while allowing Medtronic to maintain CGM integration partnerships with Abbott and Dexcom.
The exchange structure serves two strategic imperatives. First, it allows Medtronic to retire up to $4.2B in common stock at an implied 8-12% discount to net asset value, improving earnings per share without deploying cash. Second, it positions MiniMed as a standalone pure-play ahead of anticipated FDA approval for its next-generation closed-loop system in late 2025. The device, currently in Phase III trials with 1,840 participants, would compete directly against Tandem's Control-IQ and Insulet's Omnipod 5. Standalone status grants MiniMed equity currency for targeted acquisitions in the digital health layer—prescription management platforms and telehealth integration—that Medtronic's governance structure historically struggled to execute.
Allocators should track three post-announcement events. First, the IRS ruling on tax-free treatment, expected by May 12, which will confirm whether capital gains recognition applies to tendering shareholders. Second, MiniMed's S-1 filing within 15 days, which will disclose standalone debt structure and name the initial board. Third, institutional ownership reshuffling in the 30-45 days post-close as dedicated medical device funds exit and diabetes-specialist allocators enter, creating volatility windows in both securities.
The exchange offer prices at 1.1x the MiniMed carve-out valuation, implying Medtronic will accept roughly $3.8B in tendered shares to complete the separation. That's 4.3% of shares outstanding, absorbed without a cash outlay and timed six weeks ahead of the company's largest debt maturity in August.
Branded by POPS4 · proof in 60 seconds
For the principal
The tax-free exchange allows participation in the diabetes pure-play without triggering recognition events; await S-1 for debt-to-EBITDA clarity.
For the operator
Monitor institutional tender rates in the first week; heavy participation signals confidence in standalone thesis and creates entry volatility post-close.
For the house
Huang Goodman core holds initiate 2.5% position in MiniMed post-separation, hedged via Medtronic put spreads through August debt maturity.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.